RUO
Studied in selective GH-release research.
Catalog · Research summary
CJC-1295
CJC-1295 is a synthetic growth-hormone-releasing-hormone analog engineered for a longer half-life.
- CLASS
- Modified GHRH analog
- FORM
- Lyophilized powder
- PAPERWORK
- Certificate of analysis provided with every batch
- STORAGE
- −20 °C, dry, away from light
What it is
CJC-1295 is a synthetic growth-hormone-releasing-hormone analog engineered for a longer half-life.
What researchers have studied
CJC-1295 has been studied in GHRH-receptor signaling research. Published work includes:
- Sustained GH and IGF-1 signaling in pharmacology literature
- GH pulse patterns in laboratory research
- Combination studies with GH secretagogues
GH Axis
Peptides that act on the growth-hormone axis, studied for how they affect GH release in laboratory models.
This page summarizes published laboratory and animal (preclinical) research for educational purposes only. It is not a claim of safety or effectiveness in people. CJC-1295 from Helix RUO will be sold strictly for in-vitro laboratory research. Not evaluated by the FDA. Not for human or animal consumption, and not intended to diagnose, treat, cure or prevent any disease.
Related research peptides
Studied in pituitary GH research.